✉news HealthMedicine first seen 3 h ago, last 2 h ago, peak #37
FDA Sets Single IRB Rule for Multisite Trials for December 2026
Original: FDA Single IRB Rule for Multisite Trials Set for December 2026
The FDA's single institutional review board rule for multisite clinical trials will take effect in December 2026. Under the policy, one IRB will review studies conducted at multiple US sites, replacing the current patchwork of separate local reviews. Industry observers are weighing how the change will affect trial timelines, oversight responsibilities and costs for sponsors and research institutions.
Why now: Clinical trial sponsors and research sites are preparing for a major regulatory change with a set compliance deadline.
Rank over time, top of the chart is #1. 2 snapshots from 3 h ago to 2 h ago.
Evidence
- FDA Single IRB Rule for Multisite Trials Set for December 2026 · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/329695